BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1718601)

  • 1. The effects of N-glycosylation on the lectin activity of recombinant ricin B chain.
    Richardson PT; Hussain K; Woodland HR; Lord JM; Roberts LM
    Carbohydr Res; 1991 Jun; 213():19-25. PubMed ID: 1718601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the galactose binding ability of recombinant ricin B chain.
    Wales R; Richardson PT; Roberts LM; Woodland HR; Lord JM
    J Biol Chem; 1991 Oct; 266(29):19172-9. PubMed ID: 1717462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of lectin activity to a non-glycosylated ricin B chain mutant by the introduction of a novel N-glycosylation site.
    Zhan J; de Sousa M; Chaddock JA; Roberts LM; Lord JM
    FEBS Lett; 1997 May; 407(3):271-4. PubMed ID: 9175866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and secretion of a recombinant ricin immunotoxin from murine myeloma cells.
    Krek CE; Ladino CA; Goldmacher VS; Blättler WA; Guild BC
    Protein Eng; 1995 May; 8(5):481-9. PubMed ID: 8532670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant ricin B chain fragments containing a single galactose binding site retain lectin activity.
    Wales R; Richardson PT; Roberts LM; Lord JM
    Arch Biochem Biophys; 1992 Apr; 294(1):291-6. PubMed ID: 1550353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage display of ricin B chain and its single binding domains: system for screening galactose-binding mutants.
    Swimmer C; Lehar SM; McCafferty J; Chiswell DJ; Blättler WA; Guild BC
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3756-60. PubMed ID: 1373889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Asialofetuin microtitre plate-binding assay for evaluating inhibitors of ricin lectin activity.
    Dawson RM; Paddle BM; Alderton MR
    J Appl Toxicol; 1999; 19(5):307-12. PubMed ID: 10513675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preproricin expressed in Nicotiana tabacum cells in vitro is fully processed and biologically active.
    Tagge EP; Chandler J; Harris B; Czako M; Marton L; Willingham MC; Burbage C; Afrin L; Frankel AE
    Protein Expr Purif; 1996 Aug; 8(1):109-18. PubMed ID: 8812841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and functional properties of genetically engineered ricin B chain lacking galactose-binding activity.
    Vitetta ES; Yen N
    Biochim Biophys Acta; 1990 Jun; 1049(2):151-7. PubMed ID: 1694694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-site ricin B chain mutants retain galactose binding.
    Frankel A; Tagge E; Chandler J; Burbage C; Willingham M
    Protein Eng; 1996 Apr; 9(4):371-9. PubMed ID: 8738213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivalent binding of ricin to bovine serum albumin-based neoglycoconjugates.
    Blome MC; Schengrund CL
    Toxicon; 2008 Jun; 51(7):1214-24. PubMed ID: 18384830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Production of biologically active recombinant ricin B-chain].
    Tonevitskiĭ AG; Toptygin AIu; Agapov II; Rakhmanova VA; Shamshiev AT; Alekseev IuO; Pfueller U; Frankel A
    Mol Biol (Mosk); 1995; 29(2):398-406. PubMed ID: 7783743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of oligohistidine-tagged ricin B chain in Spodoptera frugiperda.
    Afrin LB; Gulick H; Vesely J; Willingham M; Frankel AE
    Bioconjug Chem; 1994; 5(6):539-46. PubMed ID: 7533004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renaturated ricin toxin B chain made in Escherichia coli is soluble, stable, and biologically active.
    Tonevitsky A; Toptygin A; Agapov I; Pfueller U; Frankel A
    Biochem Mol Biol Int; 1994 Apr; 32(6):1139-46. PubMed ID: 8061631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides.
    Lambert JM; McIntyre G; Gauthier MN; Zullo D; Rao V; Steeves RM; Goldmacher VS; Blättler WA
    Biochemistry; 1991 Apr; 30(13):3234-47. PubMed ID: 1706936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of recombinant and plant-derived mistletoe lectin and their B-chains.
    Eck J; Langer M; Möckel B; Witthohn K; Zinke H; Lentzen H
    Eur J Biochem; 1999 Oct; 265(2):788-97. PubMed ID: 10504411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chimeric toxin of the A-subunit of viscumin and the B-subunit of ricin].
    Tonevitskiĭ AG; Toptygin AIu; Agapov II; Shamshiev AT; Pfuller U; Ershova GV; Prokof'ev SA; Rakhmanova VA
    Mol Biol (Mosk); 1994; 28(3):574-9. PubMed ID: 7519722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant proricin binds galactose but does not depurinate 28 S ribosomal RNA.
    Richardson PT; Westby M; Roberts LM; Gould JH; Colman A; Lord JM
    FEBS Lett; 1989 Sep; 255(1):15-20. PubMed ID: 2676597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between immunotoxins prepared with native ricin A chains and chemically-modified ricin B chains.
    Vitetta ES
    J Immunol; 1986 Mar; 136(5):1880-7. PubMed ID: 2419417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ricin B chain fragments expressed in Escherichia coli are able to bind free galactose in contrast to the full length polypeptide.
    Wales R; Gorham HC; Hussain K; Roberts LM; Lord JM
    Glycoconj J; 1994 Aug; 11(4):274-81. PubMed ID: 7873921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.